Precision medicine -> the practice of treating diseases using insights gained from sequencing the human genome is an ...

Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...

Danaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...

The conversation centred on the company’s latest developments and strategic direction in cancer therapies, with a particular ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Today, cancer stage and tumor size tell which patients will receive adjuvant chemotherapy. But the rise of biomarker testing ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

Gene expression leading to alterations in the DNA caused by asbestos exposure may explain the development of Malignant ...

The AI in precision medicine market is experiencing significant growth, driven by the increasing global prevalence of chronic and genetic disorders, which has heightened the demand for personalized ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A new international study has revealed that most protein-level differences between men and women aren't due to genetics alone ...